The Human Genome Project, which began in the 1990s and was completed in the early 2000s to discover all human genes and map them on DNA, was one of the most important milestones in humanity and science1.
This project was followed by the Cancer Genome Atlas Project (TCGA), which started in 20062, has helped establish the importance of cancer genomics, transformed our understanding of cancer, and even begun to change how the disease is treated in the clinic3.
These genetic projects are the starting point for the innovative therapies (most of the smart cancer drugs) that are being used today and will be used in the future4.
The goal of precision oncology is simply to deliver the right cancer treatment to the right patient at the right dose and the right time5.
Genomic analysis, in particular comprehensive genomic profiling tests, is the most important tool in precision oncology6.
